Mvasi
Mvasi ingredients
| Active ingredient | Strength |
|---|---|
| Bevacizumab | 100 mg/4mL, 400 mg/16mL |
What Mvasi is used for
The FDA lists the approved uses on the official label (below). In the EU, bevacizumab is approved as Avastin for:
Bevacizumab in combination with fluoropyrimidine-based chemotherapy is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum. Bevacizumab in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer. For further information as to human epidermal growth factor receptor 2 (HER2) status. Bevacizumab in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate. Patients who have received taxane and anthracycline-containing regimens in the adjuvant setting within the last 12 months should be excluded from treatment with Avastin in combination with capecitabine. For further information as to HER2 status. Bevacizumab, in addition to…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Mvasi
- Generic name
- Bevacizumab-awwb
- Made by
- Amgen, Inc
- Forms
- Injection, Solution
- Given
- Intravenous
- Drug class
- Vascular Endothelial Growth Factor Inhibitor
- FDA approval
- Biologic licence (BLA) BLA761028
- On the US market since
- 2018
Official information
- Mvasi prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Bevacizumab-awwb)
In India
- Bevacizumab: 36 brands in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Mvasi?
Mvasi (Bevacizumab-awwb) is a cancer medicine made by Amgen, Inc, approved by the US FDA.
What are the ingredients of Mvasi?
Mvasi contains Bevacizumab (100 mg/4mL, 400 mg/16mL).
Is Mvasi approved in Europe?
The same active substance is approved in the EU as Avastin.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA